cancer clinical trials in lexington, KY
GSK Investigational Site
Lexington, Kentucky 40536-0098 Neoplasms, Breast, Breast Cancer
|
University of Kentucky
Lexington, Kentucky 40536-0098 Endometrial Cancer
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Lung Cancer
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Neuroblastoma
|
University of Kentucky
Lexington, Kentucky 40536-0098 Multiple Myeloma
|
Central Baptist Hospital
Lexington, Kentucky 40503 HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
|
University of Kentucky
Lexington, Kentucky 40536-0098 Breast Cancer
|
University of Kentucky College of Medicine
Lexington, Kentucky 40536-0084 Multiple Myeloma
|
Central Baptist Hospital
Lexington, Kentucky 40503 Lung Cancer, Radiation Toxicity
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Lung Cancer
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Leukemia
|
University of Kentucky
Lexington, Kentucky 40536-0098 Extraocular Retinoblastoma
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Leukemia
|
University of Kentucky
Lexington, Kentucky 40536-0098 Brain and Central Nervous System Tumors, Recurrent Glioblastoma Multiforme
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Neuroblastoma
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Prostate Cancer
|
University of Kentucky
Lexington, Kentucky 40536-0098 Breast Cancer
|
University of Kentucky
Lexington, Kentucky 40536-0098 Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
|
University of Kentucky
Lexington, Kentucky 40536-0098 Liver Transplantation
|
University of Kentucky Medical Center
Lexington, Kentucky 40536-0093 Breast Cancer
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Lung Cancer
|
Univ. Of Kentucky Dept. Of Surgery
Lexington, Kentucky 40536 Venous Thrombosis
|
Central Baptist Hospital
Lexington, Kentucky 40503 Non-small Cell Lung Cancer
|
Central Baptist Hospital
Lexington, Kentucky 40503 Prostate Cancer, Prostatic Cancer, Prostate Neoplasms, Prostatic Neoplasms, Cancer of the Prostate
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Leukemia
|
University of Kentucky
Lexington, Kentucky 40536-0098 Childhood Atypical Teratoid/Rhabdoid Tumor
|
University of Kentucky
Lexington, Kentucky 40536-0098 Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Lexington, Kentucky 40536 Non Small Cell Lung Cancer
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Retinoblastoma
|
GSK Investigational Site
Lexington, Kentucky 40536-0098 Neoplasms, Breast
|
University of Kentucky
Lexington, Kentucky 40536-0098 Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
|
GSK Investigational Site
Lexington, Kentucky 40536-0098 Carcinoma, Renal Cell
|
University of Kentucky
Lexington, Kentucky 40536-0098 Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Lung Cancer
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Lexington, Kentucky 40536 Non-small Cell Lung Cancer
|
University of Kentucky Hospital
Lexington, Kentucky 40536 Glioblastoma Multiforme
|
University of Kentucky
Lexington, Kentucky 40536-0098 Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
|
University of Kentucky
Lexington, Kentucky 40536-0098 Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
|
Central Baptist Hospital
Trial Locations Central Baptist Hospital University of Kentucky Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Lymphoma
|
University of Kentucky
Lexington, Kentucky 40536-0098 Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
|
University of Kentucky
Lexington, Kentucky 40536-0098 Chronic Lymphocytic Leukemia
|
University of Kentucky
Lexington, Kentucky 40536-0098 Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
|
Central Baptist Hospital
Lexington, Kentucky 40503 Ovarian Cancer
|
Central Baptist Hospital
Trial Locations Central Baptist Hospital Lucille P. Markey Cancer Center at University of Kentucky Lung Cancer
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Leukemia, Lymphoma
|
Teva Investigational Site 33
Lexington, Kentucky Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma
|
University of Kentucky Medical Center
Lexington, Kentucky 40536-0093 Breast Cancer
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Leukemia, Lymphoma
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Cancer
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Kidney Cancer, Nonneoplastic Condition
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Cancer
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Sarcoma
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Sarcoma
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Lymphoma
|
University of Kentucky
Lexington, Kentucky 40536-0098 Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Neuroblastoma
|
University of Kentucky, Markey Cancer Center
Lexington, Kentucky 40536-0093 Glioblastoma Multiforme
|
University of Kentucky
Lexington, Kentucky 40536-0098 Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Brain and Central Nervous System Tumors
|
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky 40536-0093 Metastatic Cancer, Pain
|
Associates in Neurology, P.S.C.
Lexington, Kentucky 40503 Multiple Sclerosis, Relapsing-Remitting
|
Central Baptist Hospital
Lexington, Kentucky 40503 Prostate Cancer, Sexual Dysfunction
|
Central Baptist Hospital
Trial Locations Central Baptist Hospital Lucille P. Markey Cancer Center at University of Kentucky Prostate Cancer
|